This subgroup analysis aimed to evaluate the effect of comorbidities on infrapopliteal angioplasty outcomes in patients with chronic limb-threatening ischemia (CLTI).
Methods:
This was an observational study evaluating eligible CLTI patients aged >18 years who underwent infrapopliteal angioplasty between April 2014 and May 2017 at a tertiary care center. Subgroup analyses were based on (1) baseline glycated hemoglobin (HbA1c ≤6.5% vs >6.5%), (2) presence/absence of chronic kidney disease (CKD), and (3) control of lipid parameters.
Results:
A total of 231 patients with 332 infrapopliteal vessels were treated. While diabetes was prevalent in all participants, hypertension, coronary artery disease, and CKD were reported in 76.6%, 46.3%, and 25.5% of patients at baseline, respectively. The overall technical success rate was 84.4%, and the patency rate at 6 months was 82.04%. Patency at 6 months, wound healing, in-line flow, and complete plantar arch formation were numerically higher in patients with HbA1c ≤6.5% versus >6.5%, but all comparisons were nonsignificant. According to multivariable analysis, the odds of wounds not healing was 2.38 times higher (odds ratio [OR] = 2.4, 95% confidence interval [CI]: 1.2 to 4.5) and developing plantar arch was 5.88 times higher (OR = 5.9, 95% CI: 1.3 to 25) among patients with CKD compared with patients without CKD.
Conclusions:
The 6-month outcomes of infrapopliteal angioplasty may be better in patients with controlled versus uncontrolled glycemic levels. Control of lipid parameters may not have a significant influence on outcomes, especially in patients on statin therapy. The short-term outcomes may be similar in patients with and without CKD.
Gerhard-HermanMDGornikHLBarrettC, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation2017; 135: e686-e725.
2.
NorgrenLHiattWRDormandyJA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg2007; 45: S5–S67.
3.
GrazianiLSilvestroABertoneV, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg2007; 33: 453–460.
4.
IidaOSogaYYamauchiY, et al. Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions. J Vasc Surg2013; 57: 974–981.
5.
AboyansVRiccoJBBartelinkMEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J2018; 39: 763–816.
6.
PopplewellMADaviesHOBNarayanswamiJ, et al. A comparison of outcomes in patients with infrapopliteal disease randomised to vein bypass or plain balloon angioplasty in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL) trial. Eur J Vasc Endovasc Surg2017; 54: 195–201.
7.
HsuCCKwanGNSinghD, et al. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia. Cochrane Database Syst Rev2018; 12: CD009195.
8.
KokHKAsadiHSheehanM, et al. Outcomes of infrapopliteal angioplasty for limb salvage based on the updated TASC II classification. Diagn Interv Radiol2017; 23: 360–364.
9.
AdlerAIStevensRJNeilA, et al. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care2002; 25: 894–899.
10.
MuntnerPWildmanRPReynoldsK, et al. Relationship between HbA1c level and peripheral arterial disease. Diabetes Care2005; 28: 1981–1987.
11.
SchainfeldRM.Management of peripheral arterial disease and intermittent claudication. J Am Board Fam Pract2001; 14: 443–450.
12.
SmithIFranksPJGreenhalghRM, et al. The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia. Eur J Vasc Endovasc Surg1996; 11: 402–408.
13.
SelvinEErlingerTP.Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation2004; 110: 738–743.
14.
LudersFBunzemeierHEngelbertzC, et al. CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia. Clin J Am Soc Nephrol2016; 11: 216–222.
15.
O’HareAMVittinghoffEHsiaJ, et al. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol2004; 15: 1046–1051.
16.
WillenbergTBaumannFEisenbergerU, et al. Impact of renal insufficiency on clinical outcomes in patients with critical limb ischemia undergoing endovascular revascularization. J Vasc Surg2011; 53: 1589–1597.
17.
TartagliaELejayAGeorgY, et al. Results of isolated infrapopliteal percutaneous transluminal angioplasty for critical limb ischemia in high-risk diabetic patients. Vascular2016; 24: 515–522.
18.
SiracuseJJGillHLCassidySP, et al. Endovascular treatment of lesions in the below-knee popliteal artery. J Vasc Surg2014; 60: 356–361.
19.
BrosiPBaumgartnerISilvestroA, et al. Below-the-knee angioplasty in patients with end-stage renal disease. J Endovasc Ther2005; 12: 704–713.
20.
GrazianiLSilvestroABertoneV, et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant2007; 22: 1144–1149.
21.
SöderHKManninenHIJaakkolaP, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol2000; 11: 1021–1031.
22.
KumadaYAoyamaTIshiiH, et al. Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease. Nephrol Dial Transplant2008; 23: 3996–4001.
23.
MustaphaJAFintonSMDiaz-SandovalLJ, et al. Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease: systematic review and meta-analysis. Circ Cardiovasc Interv2016; 9: e003468.
24.
GamalWWagdyWMSaluzzoC.Infrapopliteal angioplasty in diabetic and non diabetic patients. Glob Surg2015; 1: 37–41.
25.
SravanCPSVishnuMAnanadaV, et al. Drug-coated balloon versus plain balloon angioplasty for below-knee revascularization in critical ischemia: primary patency and clinical outcomes at 6 months. J Vasc Surg2018; 67: e73.
26.
WagdyWMOthmanMHMSaluzzoCM, et al. Role of infrapopliteal angioplasty in diabetic and non-diabetic patients. Egyptian J Radiol Nuclear Med2016; 47: 853–858.
27.
RyuHMKimJSKoYG, et al. Comparison of clinical outcome of infrapopliteal angioplasty between Korean diabetic and non-diabetic patients with critical limb ischemia. Circ J2012; 76: 335–341.
28.
TakaharaMKanetoHIidaO, et al. The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia. Diabetes Care2010; 33: 2538–2542.
29.
JudeEBOyiboSOChalmersN, et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care2001; 24: 1433–1437.
30.
MiyajimaSShiraiAYamamotoS, et al. Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract2006; 71: 272–279.
31.
WestinGGArmstrongEJBangH, et al. Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival rates in patients with critical limb ischemia. J Am Coll Cardiol2014; 63: 682–690.
32.
MatsiPJManninenHILaaksoM, et al. Impact of risk factors on limb salvage after angioplasty in chronic critical lower limb ischemia: a prospective trial. Angiology1994; 45: 797–804.
33.
AielloFAKhanAAMeltzerAJ, et al. Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia. J Vasc Surg2012; 55: 371–380.
34.
HondaYHiranoKYamawakiM, et al. Wound healing of critical limb ischemia with tissue loss in patients on hemodialysis. Vascular2017; 25: 272–282.
35.
MeyerASchillingAKottM, et al. Open versus endovascular revascularization of below-knee arteries in patients with end-stage renal disease and critical limb ischemia. Vasc Endovascular Surg2018; 52: 613–620.
36.
NakanoMHiranoKYamauchiY, et al. Three-year clinical outcome after infrapopliteal angioplasty for critical limb ischemia in hemodialysis patients with minor or major tissue loss. Catheter Cardiovasc Interv2015; 86: 289–298.
37.
AulivolaBGargiuloMBessoniM, et al. Infrapopliteal angioplasty for limb salvage in the setting of renal failure: do results justify its use?Ann Vasc Surg2005; 19: 762–768.
38.
NakanoMHiranoKIidaO, et al. Clinical efficacy of infrapopliteal endovascular procedures for hemodialysis patients with critical limb ischemia. Ann Vasc Surg2015; 29: 1225–1234.
39.
MarozNSimmanR.Wound healing in patients with impaired kidney function. J Am Coll Clin Wound Spec2014; 5: 2–7.
40.
SethAKDe la GarzaMFangRC, et al. Excisional wound healing is delayed in a murine model of chronic kidney disease. PLoS One2013; 8: e59979.
41.
TurgeonNAPerezSMondestinM, et al. The impact of renal function on outcomes of bariatric surgery. J Am Soc Nephrol2012; 23: 885–894.
42.
HaineAHaynesAGLimacherA, et al. Patency of the arterial pedal-plantar arch in patients with chronic kidney disease or diabetes mellitus. Ther Adv Cardiovasc Dis2018; 12: 145–153.
43.
DarlingJDMcCallumJCSodenPA, et al. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia. J Vasc Surg2017; 66: 466–475.
44.
ZlatanovicPMahmoudAACinaraI, et al. Comparison of long term outcomes after endovascular treatment versus bypass surgery in chronic limb threatening ischaemia patients with long femoropopliteal lesions. Eur J Vasc Endovasc Surg2021; 61: 258–269.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
